UBS Group AG - KRONOS BIO INC ownership

KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 95 filers reported holding KRONOS BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of KRONOS BIO INC
ValueSharesWeighting
Q3 2023$130
-99.4%
100
-99.3%
0.00%
Q1 2023$22,033
+24.5%
15,091
+38.1%
0.00%
Q4 2022$17,69910,925
+32032.4%
0.00%
Q3 2022$0
-100.0%
34
-100.0%
0.00%
Q1 2022$674,000
+7.2%
93,236
+101.4%
0.00%
Q4 2021$629,000
+1210.4%
46,296
+1916.4%
0.00%
Q3 2021$48,000
-4.0%
2,296
+9.5%
0.00%
Q2 2021$50,000
-15.3%
2,096
+4.6%
0.00%
Q1 2021$59,000
-14.5%
2,003
-13.1%
0.00%
Q4 2020$69,0002,3050.00%
Other shareholders
KRONOS BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,765,314$9,264,0008.31%
Omega Fund Management, LLC 3,818,283$12,791,0004.68%
Privium Fund Management (UK) Ltd 645,331$2,162,0002.76%
Wildcat Capital Management, LLC 1,438,232$4,818,0001.85%
Nextech Invest Ltd. 1,451,537$4,863,0001.57%
Alphabet Inc. 1,438,232$4,818,0000.25%
Artal Group S.A. 1,542,954$5,169,0000.22%
Perceptive Advisors 2,156,151$7,223,0000.21%
Oasis Management Co Ltd. 196,078$657,0000.11%
PARTNERS CAPITAL INVESTMENT GROUP, LLP 527,500$1,767,0000.10%
View complete list of KRONOS BIO INC shareholders